Sartorius Stedim Biotech (WBO:DIM) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:DIM Sartorius Stedim Biotech SA WBO:DIM
90 GF Score
Price €187.10
GF Value €206.43
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

WBO:DIM
90GF Score
Sartorius Stedim Biotech SA WBO:DIM
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sartorius Stedim Biotech (WBO:DIM) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of €187.10 is trading 9.4% below its estimated GF Value™ of €206.43.

Key valuation signals for WBO:DIM:

  • Short Ratio:
  • GF Value™: €206.43 vs. price of €187.10 (9.4% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the WBO:DIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
90GF Score

Get the complete analysis for WBO:DIM

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€187.10
Price
€206.43
GF Value